Literature DB >> 22556133

Mammalian target of rapamycin integrates diverse inputs to guide the outcome of antigen recognition in T cells.

Adam T Waickman1, Jonathan D Powell.   

Abstract

T cells must integrate a diverse array of intrinsic and extrinsic signals upon Ag recognition. Although these signals have canonically been categorized into three distinct events--Signal 1 (TCR engagement), Signal 2 (costimulation or inhibition), and Signal 3 (cytokine exposure)--it is now appreciated that many other environmental cues also dictate the outcome of T cell activation. These include nutrient availability, the presence of growth factors and stress signals, as well as chemokine exposure. Although all of these distinct inputs initiate unique signaling cascades, they also modulate the activity of the evolutionarily conserved serine/threonine kinase mammalian target of rapamycin (mTOR). Indeed, mTOR serves to integrate these diverse environmental inputs, ultimately transmitting a signaling program that determines the fate of newly activated T cells. In this review, we highlight how diverse signals from the immune microenvironment can guide the outcome of TCR activation through the activation of the mTOR pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556133      PMCID: PMC3347776          DOI: 10.4049/jimmunol.1103143

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  124 in total

1.  The CD28 signaling pathway regulates glucose metabolism.

Authors:  Kenneth A Frauwirth; James L Riley; Marian H Harris; Richard V Parry; Jeffrey C Rathmell; David R Plas; Rebecca L Elstrom; Carl H June; Craig B Thompson
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

Review 2.  Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation.

Authors:  Josep M Campistol; Paul Cockwell; Fritz Diekmann; Donato Donati; Luis Guirado; Gustaf Herlenius; Dujanah Mousa; Johann Pratschke; Juan Carlos Ruiz San Millán
Journal:  Transpl Int       Date:  2009-04-06       Impact factor: 3.782

Review 3.  mTOR signaling at a glance.

Authors:  Mathieu Laplante; David M Sabatini
Journal:  J Cell Sci       Date:  2009-10-15       Impact factor: 5.285

Review 4.  Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration.

Authors:  David Finlay; Doreen Cantrell
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

5.  IL-7 enhances the survival and maintains the size of naive T cells.

Authors:  J C Rathmell; E A Farkash; W Gao; C B Thompson
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

6.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.

Authors:  Ken Inoki; Yong Li; Tianquan Zhu; Jun Wu; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2002-09       Impact factor: 28.824

7.  Anergic T cells are metabolically anergic.

Authors:  Yan Zheng; Greg M Delgoffe; Christian F Meyer; Waipan Chan; Jonathan D Powell
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

8.  The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.

Authors:  Muhammet F Gulen; Zizhen Kang; Katarzyna Bulek; Wan Youzhong; Tae Whan Kim; Yi Chen; Cengiz Z Altuntas; Kristian Sass Bak-Jensen; Mandy J McGeachy; Jeong-Su Do; Hui Xiao; Greg M Delgoffe; Booki Min; Jonathan D Powell; Vincent K Tuohy; Daniel J Cua; Xiaoxia Li
Journal:  Immunity       Date:  2010-01-07       Impact factor: 31.745

9.  MAPK, phosphatidylinositol 3-kinase, and mammalian target of rapamycin pathways converge at the level of ribosomal protein S6 phosphorylation to control metabolic signaling in CD8 T cells.

Authors:  Robert J Salmond; Juliet Emery; Klaus Okkenhaug; Rose Zamoyska
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

10.  PD-L1 regulates the development, maintenance, and function of induced regulatory T cells.

Authors:  Loise M Francisco; Victor H Salinas; Keturah E Brown; Vijay K Vanguri; Gordon J Freeman; Vijay K Kuchroo; Arlene H Sharpe
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

View more
  29 in total

1.  Resveratrol attenuates stimulated T-cell activation and proliferation: potential therapy against cellular rejection in organ transplantation.

Authors:  Jimmy Jh Kang; Sabin J Bozso; Dana E Boe; David P Al-Adra; Michael C Moon; Darren H Freed; Jayan Nagendran; Jeevan Nagendran
Journal:  Am J Clin Exp Immunol       Date:  2020-12-15

2.  Targeting the class IA PI3K isoforms p110α/δ attenuates heart allograft rejection in mice by suppressing the CD4+ T lymphocyte response.

Authors:  Chuanlei Yang; Xing Chen; Zhanjie Wei; Jie Xiao; Weiqiang Chen; Yuqiang Shang; Jinping Liu
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

3.  Angioedema in patients treated with sirolimus and ACE inhibitor post hematopoietic SCT.

Authors:  M Jung; V N Ranpura; C E Dunbar; J F Tisdale; C D Fitzhugh; M M Hsieh
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

Review 4.  Metabolic control of the Treg/Th17 axis.

Authors:  Joseph Barbi; Drew Pardoll; Fan Pan
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

5.  TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1.

Authors:  Nina Chi Sabins; Olesya Chornoguz; Karen Leander; Fred Kaplan; Richard Carter; Michelle Kinder; Kurtis Bachman; Raluca Verona; Shixue Shen; Vipul Bhargava; Sandra Santulli-Marotto
Journal:  J Immunol       Date:  2017-11-10       Impact factor: 5.422

6.  Controlled Release of Second Generation mTOR Inhibitors to Restrain Inflammation in Primary Immune Cells.

Authors:  Emily A Gosselin; Lisa H Tostanoski; Christopher M Jewell
Journal:  AAPS J       Date:  2017-05-08       Impact factor: 4.009

Review 7.  Immunometabolism and autoimmunity.

Authors:  Jenny Freitag; Luciana Berod; Thomas Kamradt; Tim Sparwasser
Journal:  Immunol Cell Biol       Date:  2016-08-26       Impact factor: 5.126

Review 8.  mTOR, linking metabolism and immunity.

Authors:  Xiaojin Xu; Lilin Ye; Koichi Araki; Rafi Ahmed
Journal:  Semin Immunol       Date:  2013-01-24       Impact factor: 11.130

9.  Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

Authors:  Matthew M Hsieh; Courtney D Fitzhugh; R Patrick Weitzel; Mary E Link; Wynona A Coles; Xiongce Zhao; Griffin P Rodgers; Jonathan D Powell; John F Tisdale
Journal:  JAMA       Date:  2014-07-02       Impact factor: 56.272

Review 10.  Signal transduction via the T cell antigen receptor in naïve and effector/memory T cells.

Authors:  Arun Kannan; Weishan Huang; Fei Huang; Avery August
Journal:  Int J Biochem Cell Biol       Date:  2012-09-04       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.